Indication
Ogsiveo as monotherapy is indicated for the treatment of adult patients with progressing desmoid tumours who require systemic treatment.
In other countries
The same active substances on other registers, the same brand first.
National listings
The national registers that list this EU medicine.
- Ogsiveo 100 MG Comprimidos Recubiertos con PeliculaSpain · 133,04 mgAuthorised
- Ogsiveo 150 MG Comprimidos Recubiertos con PeliculaSpain · 199,574 mgAuthorised
- Ogsiveo 100 mg filmomhulde tablettenNetherlandsAuthorised
- Ogsiveo 150 mg filmomhulde tablettenNetherlandsAuthorised
- Ogsiveo 50 mg filmomhulde tablettenNetherlandsAuthorised